Article
Isovaleric aciduria identified by newborn screening: Strategies to predict disease severity and stratify treatment.
Journal of inherited metabolic disease - 1 Nov 2023
Mütze Ulrike, Henze Lucy, Schröter Julian, Gleich Florian, Lindner Martin, Grünert Sarah C, Spiekerkoetter Ute, Santer René, Thimm Eva, Ensenauer Regina, Weigel Johannes, Beblo Skadi, Arélin Maria, Hennermann Julia B, Marquardt Iris, Freisinger Peter, Krämer Johannes, Dieckmann Andrea, Weinhold Natalie, Schiergens Katharina A, Maier Esther M, Hoffmann Georg F, Garbade Sven F, Kölker Stefan
Abstract excerpt
Newborn screening (NBS) allows early identification of individuals with rare disease, such as isovaleric aciduria (IVA). Reliable early prediction of disease severity of positively screened individuals with IVA is needed to guide therapeutic decision, prevent life-threatening neonatal disease manifestation in classic IVA and over-medicalization in attenuated IVA that may remain asymptomatic. We analyzed 84...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
